Search

Author/Creator Callegari, Francesca

1. Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy. Issue 10 (October 2021)

Authors:
Rice, Andrew S.C.; Dworkin, Robert H.; Finnerup, Nanna B.; Attal, Nadine; Anand, Praveen; Freeman, Roy; Piaia, Alessandro; Callegari, Francesca; Doerr, Christie; Mondal, Subhayan; Narayanan, Nisha; Ecochard, Laurent; Flossbach, Yanina; Pandhi, Shaloo
Journal:
Pain
Issue:
Volume 162:Issue 10(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24‐week, Randomized, Double‐Blind Parallel‐Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily). (25th March 2016)

Authors:
Zhang, Zhen‐Xin; Hong, Zhen; Wang, Yan‐Ping; He, Li; Wang, Ning; Zhao, Zhong‐Xin; Zhao, Gang; Shang, Lan; Weisskopf, Marianne; Callegari, Francesca; Strohmaier, Christine
Journal:
CNS neuroscience & therapeutics
Issue:
Volume 22:Number 6(2016)
Page Start:
488
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗